Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Pharmacokinetics of Co-formulated Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Smear-positive Pulmonary Tuberculosis in the Kilimanjaro Region, Tanzania

NCT00474435 is registered in ClinicalTrials.gov with African Poverty Related Infection Oriented Research Initiative as lead sponsor.

NCT NCT00474435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00474435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Pharmacokinetics of Co-formulated Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With Smear-positive Pulmonary Tuberculosis in the Kilimanjaro Region, Tanzania
Lead sponsor
African Poverty Related Infection Oriented Research Initiative
Phase
Phase 2
Overall status
Unknown status
Start date
November 30, 2008
Completion date
December 31, 2009
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, tuberculosis